{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:33:37Z","timestamp":1792096417943,"version":"4.4.0"},"reference-count":212,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretariat of Science Humanities Technology and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005343","name":"IMSS AC Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbiological Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.micres.2026.128536","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:51:36Z","timestamp":1777567896000},"page":"128536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Therapeutic targeting of Respiratory Syncytial Virus: Current pharmacological options and future directions in antiviral development"],"prefix":"10.1016","volume":"309","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9082-5594","authenticated-orcid":false,"given":"Luisa Fernanda","family":"Ontiveros-Z\u00fa\u00f1iga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4234-6640","authenticated-orcid":false,"given":"Sharon Itzel","family":"Sosa-Mondragon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8280-9812","authenticated-orcid":false,"given":"Juan Fidel","family":"Osuna-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9371-0238","authenticated-orcid":false,"given":"Randy Seir","family":"Llanas-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8050-4587","authenticated-orcid":false,"given":"David Mauricio","family":"Ca\u00f1edo-Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Adri\u00e1n","family":"Vel\u00e1zquez-Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Paul","family":"Miranda-Liz\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9988-6504","authenticated-orcid":false,"given":"Andrea","family":"Laredo-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4827-8281","authenticated-orcid":false,"given":"Luis Enrique","family":"Flores-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5508-0077","authenticated-orcid":false,"given":"Giovanna Berenice","family":"Barrera-Aveleida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4853-3063","authenticated-orcid":false,"given":"Alan Orlado","family":"Santos-Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"\u00c1lvarez-Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2760-697X","authenticated-orcid":false,"given":"Jonathan","family":"Hern\u00e1ndez-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-6260","authenticated-orcid":false,"given":"Luis Adri\u00e1n","family":"De Jes\u00fas-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micres.2026.128536_bib1","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1016\/j.vaccine.2016.09.011","article-title":"Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: a case-population study","volume":"34","author":"Abadom","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.micres.2026.128536_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40506-025-00285-6","article-title":"The role of ribavirin for treatment of respiratory syncytial virus in immunocompromised patients","volume":"17","author":"Abbas","year":"2025","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/ciy991","article-title":"Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults","volume":"69","author":"Ackerson","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa2108903","article-title":"EDP-938, a respiratory syncytial virus inhibitor, in a human virus challenge","volume":"386","author":"Ahmad","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micres.2026.128536_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1624007","article-title":"Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia","volume":"16","author":"Alandijany","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micres.2026.128536_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40266-024-01118-9","article-title":"Respiratory syncytial virus infection in older adults: an update","volume":"41","author":"Alfano","year":"2024","journal-title":"Drugs Aging"},{"key":"10.1016\/j.micres.2026.128536_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5339\/qmj.2024.56","article-title":"Respiratory syncytial virus: A review of current basic and clinical knowledge","volume":"2024","author":"Al-leimon","year":"2024","journal-title":"Qatar Med. J."},{"key":"10.1016\/j.micres.2026.128536_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/irv.12781","article-title":"Etiologies of severe acute respiratory infection (SARI) and misdiagnosis of influenza in Indonesia, 2013-2016","volume":"15","author":"Aman","year":"2021","journal-title":"Influenza Other Respir. Virus"},{"key":"10.1016\/j.micres.2026.128536_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1542\/peds.92.3.501","article-title":"Use of ribavirin in the treatment of respiratory syncytial virus infection","volume":"92","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.micres.2026.128536_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/vaccines9090961","article-title":"Bringing preventive RSV monoclonal antibodies to infants in low- and middle-income countries: challenges and opportunities","volume":"9","author":"Ananworanich","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.micres.2026.128536_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/vaccines13020097","article-title":"Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines","volume":"13","author":"Anastassopoulou","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.micres.2026.128536_bib12","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/jvi.62.11.4232-4238.1988","article-title":"Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies","volume":"62","author":"Anderson","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib13","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.3390\/jcm14113880","article-title":"Respiratory Syncytial Virus: A Narrative Review of Updates and Recent Advances in Epidemiology, Pathogenesis, Diagnosis, Management and Prevention","volume":"14","author":"Asseri","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.micres.2026.128536_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4269\/ajtmh.14-0191","article-title":"Rickettsial infections in Southeast Asia: implications for local populace and febrile returned travelers","volume":"91","author":"Aung","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.micres.2026.128536_bib15","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1099\/vir.0.053025-0","article-title":"The respiratory syncytial virus nucleoprotein-RNA complex forms a left-handed helical nucleocapsid","volume":"94","author":"Bakker","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2014.02.010","article-title":"Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein","volume":"454\u2013455","author":"Bates","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.micres.2026.128536_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nchembio.1982","article-title":"Molecular mechanism of respiratory syncytial virus fusion inhibitors","volume":"12","author":"Battles","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.micres.2026.128536_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41579-019-0149-x","article-title":"Respiratory syncytial virus entry and how to block it","volume":"17","author":"Battles","year":"2019","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.micres.2026.128536_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/jiad024","article-title":"Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial","volume":"228","author":"Bebia","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib20","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1073\/pnas.96.20.11259","article-title":"The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription","volume":"96","author":"Bermingham","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micres.2026.128536_bib21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jiph.2019.04.013","article-title":"A case report of the enterovirus-D68 associated severe acute respiratory illness in a pediatric case from India","volume":"12","author":"Bhardwaj","year":"2019","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.micres.2026.128536_bib22","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/jpc.16197","article-title":"Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions","volume":"58","author":"Binns","year":"2022","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.micres.2026.128536_bib23","unstructured":"Biopharma, C., 2026. Clover Initiates Phase 2 Clinical Trial for RSV + hMPV \u00b1 PIV3 Respiratory Combination Vaccine Candidates [WWW Document]. URL \u3008https:\/\/www.prnewswire.com\/news-releases\/clover-initiates-phase-2-clinical-trial-for-rsv--hmpv--piv3-respiratory-combination-vaccine-candidates-302658139.html\u3009 (accessed 1.11.26)."},{"key":"10.1016\/j.micres.2026.128536_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17476348.2024.2331764","article-title":"So we now have RSV vaccines. What\u2019s our next steps?","volume":"18","author":"Blondeau","year":"2024","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.micres.2026.128536_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12016-013-8368-9","article-title":"Respiratory Syncytial Virus\u2014A Comprehensive Review","volume":"45","author":"Borchers","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.micres.2026.128536_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40266-015-0258-9","article-title":"Respiratory Syncytial Virus Infection in Older Adults: An Under-Recognized Problem","volume":"32","author":"Branche","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.micres.2026.128536_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40121-024-01081-3","article-title":"A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection","volume":"14","author":"Branche","year":"2025","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.micres.2026.128536_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12879-015-0827-x","article-title":"Severe acute respiratory infection in children in a densely populated urban slum in Kenya, 2007-2011","volume":"15","author":"Breiman","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/mmi.15133","article-title":"Respiratory syncytial virus entry mechanism in host cells: A general overview","volume":"120","author":"Cadena-Cruz","year":"2023","journal-title":"Mol. Microbiol"},{"key":"10.1016\/j.micres.2026.128536_bib30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/v13050834","article-title":"Structural Insights into the Respiratory Syncytial Virus RNA Synthesis Complexes","volume":"13","author":"Cao","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2026.128536_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/14787210.2025.2481908","article-title":"Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children","author":"Carbonell-Estrany","year":"2025","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.micres.2026.128536_bib32","doi-asserted-by":"crossref","unstructured":"Cardinale, D., Grant, O., Hyang Lee, D.D., Hynds, R.E., Angell, R., O\u2019Callaghan, C., Cortina-Borja, M., Thomas, E., Smith, C.M., 2025. Donor-derived airway ALI model for high-throughput screening of antiviral combinations with concurrent analysis of antiviral efficacy and epithelial toxicity using ciliR. https:\/\/doi.org\/10.1101\/2025.03.28.645652.","DOI":"10.1101\/2025.03.28.645652"},{"key":"10.1016\/j.micres.2026.128536_bib33","first-page":"281","article-title":"Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA)","volume":"66","author":"Chanock","year":"1957","journal-title":"I. Isol. Prop. Charact. Am. J. Hyg."},{"key":"10.1016\/j.micres.2026.128536_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12879-018-3002-3","article-title":"Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study","volume":"18","author":"Chatzis","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib35","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/cid\/ciz1166","article-title":"A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients","volume":"71","author":"Chemaly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcv.2017.08.017","article-title":"Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal","volume":"Virol. 95","author":"Chu","year":"2017","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin."},{"key":"10.1016\/j.micres.2026.128536_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1377968","article-title":"Respiratory syncytial virus disease burden in children and adults from Latin America: a systematic review and meta-analysis","volume":"12","author":"Ciapponi","year":"2024","journal-title":"Front. Public Health"},{"key":"10.1016\/j.micres.2026.128536_bib38","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/acs.jmedchem.0c01882","article-title":"Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion","volume":"64","author":"Cockerill","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micres.2026.128536_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.micres.2026.128536_bib40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.aav9033","article-title":"A proof of concept for structure-based vaccine design targeting RSV in humans","volume":"365","author":"Crank","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.micres.2026.128536_bib41","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/infdis\/jiac253","article-title":"Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV\/\u0394NS2\/\u03941313\/I1314L and RSV\/276 in RSV-Seronegative Children","volume":"226","author":"Cunningham","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib42","unstructured":"DailyMed - VIRAZOLE- ribavirin powder, for solution [WWW Document], n.d. URL \u3008https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=adf16e64-345f-469a-b987-3fbdd17e0ac2\u3009 (accessed 4.13.26)."},{"key":"10.1016\/j.micres.2026.128536_bib43","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved Antiviral Drugs over the Past 50 Years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micres.2026.128536_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/pathogens14010020","article-title":"Advances and Challenges in Antiviral Development for Respiratory Viruses","volume":"14","author":"De Jes\u00fas-Gonz\u00e1lez","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.micres.2026.128536_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/vaccines13030304","article-title":"Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods","volume":"13","author":"Deng","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.micres.2026.128536_bib46","article-title":"Risk factors for respiratory syncytial virus-associated acute lower respiratory infection in children under 5 years: An updated systematic review and meta-analysis","volume":"146","author":"Deng","year":"2024","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107125","article-title":"Risk factors for respiratory syncytial virus-associated acute lower respiratory infection in children under 5 years: An updated systematic review and meta-analysis","volume":"146","author":"Deng","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1173842","article-title":"Epidemiology and risk factors of respiratory syncytial virus associated acute respiratory tract infection in hospitalized children younger than 5 years from Sri Lanka","volume":"14","author":"Divarathna","year":"2023","journal-title":"Front. Microbiol"},{"key":"10.1016\/j.micres.2026.128536_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40121-020-00383-6","article-title":"The Future of Respiratory Syncytial Virus Disease Prevention and Treatment","volume":"10","author":"Domachowske","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.micres.2026.128536_bib50","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1128\/AAC.00771-12","article-title":"Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide","volume":"56","author":"Donalisio","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micres.2026.128536_bib51","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","article-title":"Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants","volume":"389","author":"Drysdale","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micres.2026.128536_bib52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-024-03431-7","article-title":"Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults","volume":"31","author":"Du","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.micres.2026.128536_bib53","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.46234\/ccdcw2023.206","article-title":"Nowcasting and Forecasting Seasonal Influenza Epidemics \u2014 China, 2022\u20132023","volume":"5","author":"Du","year":"2023","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.micres.2026.128536_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.880368","article-title":"RSV Prevention in All Infants: Which Is the Most Preferable Strategy?","volume":"13","author":"Esposito","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micres.2026.128536_bib55","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/v15091848","article-title":"Clinical Characterization of Respiratory Syncytial Virus Infection in Adults: A Neglected Disease?","volume":"15","author":"Estofolete","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2026.128536_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-98907-y","article-title":"Incidence of common respiratory pathogens among patients with severe acute respiratory infection during COVID-19 pandemic in Egypt","volume":"15","author":"Fahmy","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micres.2026.128536_bib57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcv.2005.04.004","article-title":"Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness","volume":"35","author":"Falsey","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib58","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/infdis\/jit839","article-title":"Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness","volume":"209","author":"Falsey","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.13.3.371","article-title":"Respiratory Syncytial Virus Infection in Adults","author":"Falsey","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micres.2026.128536_bib60","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1128\/JVI.74.13.6006-6014.2000","article-title":"Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus","volume":"74","author":"Fearns","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2016.08.006","article-title":"New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase","volume":"134","author":"Fearns","year":"2016","journal-title":"Antivir. Res"},{"key":"10.1016\/j.micres.2026.128536_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar3534","article-title":"Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies","volume":"3","author":"Fedechkin","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.micres.2026.128536_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virs.2025.01.003","article-title":"Current antiviral therapies and promising drug candidates against respiratory syncytial virus infection","volume":"40","author":"Feng","year":"2025","journal-title":"Virol. Sin."},{"key":"10.1016\/j.micres.2026.128536_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virs.2025.01.003","article-title":"Current antiviral therapies and promising drug candidates against respiratory syncytial virus infection","volume":"40","author":"Feng","year":"2025","journal-title":"Virol. Sin."},{"key":"10.1016\/j.micres.2026.128536_bib65","first-page":"216","article-title":"Clinical and epidemiological impact of respiratory syncytial virus and identification of risk factors for severe disease in children hospitalized due to acute respiratory tract infection","volume":"117","author":"Ferolla","year":"2019","journal-title":"Arch. Argent. Pedia"},{"key":"10.1016\/j.micres.2026.128536_bib66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40272-024-00625-x","article-title":"CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged \u2265 28 Days and \u2264 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus","volume":"26","author":"Ferrero","year":"2024","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.micres.2026.128536_bib67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2471\/BLT.17.194514","article-title":"Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection","volume":"96","author":"Fitzner","year":"2018","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.micres.2026.128536_bib68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.anpedi.2023.09.006","article-title":"Nirsevimab para la prevenci\u00f3n de la enfermedad por virus respiratorio sincitial en ni\u00f1os. Posicionamiento de la Sociedad Espa\u00f1ola de Infectolog\u00eda Pedi\u00e1trica","volume":"99","author":"Francisco","year":"2023","journal-title":"An. Pedia \u00eda"},{"key":"10.1016\/j.micres.2026.128536_bib69","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01046-24","article-title":"vitro higher-order oligomeric assembly of the respiratory syncytial virus M2-1 protein with longer RNAs","volume":"98","author":"Gao","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/JCM.02093-15","article-title":"Are Pathogenic Leptospira Species Agents of Community-Acquired Pneumonia? Case Reports of Leptospirosis Presenting as Pneumonia","volume":"54","author":"Gasem","year":"2016","journal-title":"J. Clin. Microbiol"},{"key":"10.1016\/j.micres.2026.128536_bib71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/pathogens12020154","article-title":"Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)","volume":"12","author":"Gatt","year":"2023","journal-title":"Pathog. Basel Switz."},{"key":"10.1016\/j.micres.2026.128536_bib72","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1128\/JVI.02374-08","article-title":"The Respiratory Syncytial Virus Matrix Protein Possesses a Crm1-Mediated Nuclear Export Mechanism","volume":"83","author":"Ghildyal","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib73","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1099\/0022-1317-83-4-753","article-title":"Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells","volume":"83","author":"Ghildyal","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib74","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/B978-0-7020-6896-6.00038-7","article-title":"Immune Deficiencies at the Extremes of Age","author":"Goronzy","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.micres.2026.128536_bib75","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.healun.2023.01.013","article-title":"A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant","volume":"42","author":"Gottlieb","year":"2023","journal-title":"J. Heart Lung Transpl."},{"key":"10.1016\/j.micres.2026.128536_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00457-07","article-title":"Coupled Translation of the Second Open Reading Frame of M2 mRNA Is Sequence Dependent and Differs Significantly within the Subfamily Pneumovirinae","author":"Gould","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib77","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-biochem-013118-111843","article-title":"Ribonucleotide Reductases: Structure, Chemistry, and Metabolism Suggest New Therapeutic Targets","volume":"89","author":"Greene","year":"2020","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.micres.2026.128536_bib78","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41586-020-2369-7","article-title":"IGF1R is an entry receptor for respiratory syncytial virus","volume":"583","author":"Griffiths","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micres.2026.128536_bib79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/jinf.2002.1015","article-title":"Respiratory syncytial virus--viral biology and the host response","volume":"45","author":"Hacking","year":"2002","journal-title":"J. Infect."},{"key":"10.1016\/j.micres.2026.128536_bib80","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The Burden of Respiratory Syncytial Virus Infection in Young Children","volume":"360","author":"Hall","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micres.2026.128536_bib81","first-page":"210","article-title":"Basic epidemiology and immunopathology of RSV in children","volume":"1","author":"Handforth","year":"2000","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.micres.2026.128536_bib82","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf695.738","article-title":"P-523. Zelicapavir (EDP-938) Antiviral Treatment is Associated with Shortened Duration of RSV Symptoms in a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial in Children 28 Days to 36 Months of Age","volume":"13","author":"Harris","year":"2026","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib83","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1165\/rcmb.2002-0100OC","article-title":"Increased susceptibility to RSV infection by exposure to inhaled diesel engine emissions","volume":"28","author":"Harrod","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.micres.2026.128536_bib84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40248-019-0174-7","article-title":"Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): results from the Egyptian surveillance study 2010\u20132014","volume":"14","author":"Hatem","year":"2019","journal-title":"Multidiscip. Respir. Med."},{"key":"10.1016\/j.micres.2026.128536_bib85","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/infdis\/jiaa029","article-title":"Respiratory Syncytial Virus Antivirals: Problems and Progress","volume":"222","author":"Hayden","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib86","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/viro.2002.1540","article-title":"Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins","volume":"300","author":"Henderson","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.micres.2026.128536_bib87","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.virusres.2014.07.031","article-title":"Identification of cellular proteins that interact with Newcastle Disease Virus and human Respiratory Syncytial Virus by a two-dimensional virus overlay protein binding assay (VOPBA)","volume":"191","author":"Holguera","year":"2014","journal-title":"Virus Res"},{"key":"10.1016\/j.micres.2026.128536_bib88","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41541-024-01002-y","article-title":"Regulatory review of benefits and risks of preventing infant RSV disease through maternal immunization","volume":"9","author":"Hong-Nguyen","year":"2024","journal-title":"Npj Vaccin."},{"key":"10.1016\/j.micres.2026.128536_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.114441","article-title":"Heterogeneity of Clinical Phenotypes in Severe Acute Respiratory Infections Owing to Respiratory Syncytial Virus: A Need to Look Beyond Hospitalization","volume":"278","author":"Horvat","year":"2025","journal-title":"J. Pedia"},{"key":"10.1016\/j.micres.2026.128536_bib90","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.apsb.2023.01.006","article-title":"Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies","volume":"13","author":"Hou","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.micres.2026.128536_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007084","article-title":"Risk factors for hospitalization of patients with chikungunya virus infection at sentinel hospitals in Puerto Rico","volume":"13","author":"Hsu","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib92","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42448","article-title":"Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production","volume":"8","author":"Hu","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.micres.2026.128536_bib93","article-title":"Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial","volume":"17","author":"Huang","year":"2023","journal-title":"Influenza Other Respir. Virus"},{"key":"10.1016\/j.micres.2026.128536_bib94","article-title":"Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial","volume":"17","author":"Huang","year":"2023","journal-title":"Influenza Other Respir. Virus"},{"key":"10.1016\/j.micres.2026.128536_bib95","doi-asserted-by":"crossref","first-page":"s6","DOI":"10.35366\/118344","article-title":"Consenso de la Asociaci\u00f3n Mexicana de Infectolog\u00eda Pedi\u00e1trica (AMIP): prevenci\u00f3n de la infecci\u00f3n por virus sincitial respiratorio en M\u00e9xico, 2024","volume":"37","author":"Ibarra","year":"2024","journal-title":"Rev. Latinoam. Infectol. Pedi\u00e1trica"},{"key":"10.1016\/j.micres.2026.128536_bib96","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2500026","article-title":"Live-Attenuated Intranasal RSV Vaccine in Infants and Toddlers","volume":"4","author":"Idoko","year":"2025","journal-title":"NEJM Evid."},{"key":"10.1016\/j.micres.2026.128536_bib97","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs","volume":"64","author":"Jeon","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micres.2026.128536_bib98","series-title":"SARS, MERS and Other Viral Lung Infections, Wellcome Trust\u2013Funded Monographs and Book Chapters","article-title":"Respiratory Syncytial Virus","author":"Jha","year":"2016"},{"key":"10.1016\/j.micres.2026.128536_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005318","article-title":"Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures","volume":"11","author":"Johnson","year":"2015","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.micres.2026.128536_bib100","doi-asserted-by":"crossref","DOI":"10.1177\/2040206618764483","article-title":"Nucleosides for the treatment of respiratory RNA virus infections","volume":"26","author":"Jordan","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.micres.2026.128536_bib101","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/v17081030","article-title":"Association of Comorbidities with Adverse Outcomes in Adults Hospitalized with Respiratory Syncytial Virus (RSV) Infection: A Retrospective Cohort Study from Switzerland (2022\u20132024)","volume":"17","author":"Joseph","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2026.128536_bib102","article-title":"Respiratory Syncytial Virus: A Comprehensive Review of Transmission, Pathophysiology, and Manifestation","volume":"15","author":"Kaler","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.micres.2026.128536_bib103","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micres.2026.128536_bib104","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micres.2026.128536_bib105","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1164\/rccm.202005-1660OC","article-title":"Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children","volume":"203","author":"Karron","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.micres.2026.128536_bib106","article-title":"The recent landscape of RSV vaccine research","volume":"13","author":"Kelleher","year":"2025","journal-title":"Ther. Adv. Vaccin. Immunother."},{"key":"10.1016\/j.micres.2026.128536_bib107","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.micres.2026.128536_bib108","doi-asserted-by":"crossref","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","article-title":"PubChem 2025 update","volume":"53","author":"Kim","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.micres.2026.128536_bib109","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/v15081713","article-title":"Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children","volume":"15","author":"Kobia\u0142ka","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2026.128536_bib110","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.12.04050","article-title":"Respiratory syncytial virus among children hospitalized with severe acute respiratory infection in Kashmir, a temperate region in northern India","volume":"12","author":"Koul","year":"2022","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.micres.2026.128536_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003309","article-title":"Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein","volume":"9","author":"Krzyzaniak","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micres.2026.128536_bib112","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/jvi.70.10.6892-6901.1996","article-title":"Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus","volume":"70","author":"Kuo","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib113","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2303796","article-title":"Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States","volume":"20","author":"La","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.micres.2026.128536_bib114","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/cid\/cit471","article-title":"High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections","volume":"57","author":"Lee","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/vaccines11020367","article-title":"Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine","volume":"11","author":"Leroux-Roels","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.micres.2026.128536_bib116","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/00185787241298140","article-title":"Respiratory Syncytial Virus Vaccine (mRNA)","volume":"60","author":"Levien","year":"2025","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.micres.2026.128536_bib117","article-title":"Viral etiology of severe acute respiratory infections in hospitalized patients, Shandong, China","volume":"20","author":"Li","year":"2025","journal-title":"PloS One"},{"key":"10.1016\/j.micres.2026.128536_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70016","article-title":"Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue","volume":"5","author":"Li","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.micres.2026.128536_bib119","article-title":"Etiological and epidemiological characteristics of severe acute respiratory infection caused by multiple viruses and Mycoplasma pneumoniae in adult patients in Jinshan, Shanghai: A pilot hospital-based surveillance study","volume":"16","author":"Li","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.micres.2026.128536_bib120","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.micres.2026.128536_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70403","article-title":"Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Its Implications for Prophylactic and Therapeutic Pharmaceuticals","volume":"6","author":"Liang","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.micres.2026.128536_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011342","article-title":"4\u2019-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses","volume":"19","author":"Lieber","year":"2023","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.micres.2026.128536_bib123","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOP.0000000000001336","article-title":"Recent advances in the prevention of respiratory syncytial virus in pediatrics","volume":"36","author":"Lipp","year":"2024","journal-title":"Curr. Opin. Pedia"},{"key":"10.1016\/j.micres.2026.128536_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1724561","article-title":"Internalization-related host factors of common respiratory viruses","volume":"16","author":"Lv","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micres.2026.128536_bib125","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3111\/13696998.2012.690013","article-title":"Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective","volume":"15","author":"Mahadevia","year":"2012","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.micres.2026.128536_bib126","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/vaccines11020491","article-title":"Respiratory Syncytial Virus Infection: Treatments and Clinical Management","volume":"11","author":"Malik","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.micres.2026.128536_bib127","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cmi.2023.04.021","article-title":"Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"29","author":"Manothummetha","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micres.2026.128536_bib128","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/cid\/ciz1167","volume":"71","author":"Marty","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib129","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coviro.2015.03.002","article-title":"Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein","volume":"11","author":"McLellan","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib130","series-title":"Challenges and Opportunities for Respiratory Syncytial Virus Vaccines","first-page":"83","article-title":"Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins","author":"McLellan","year":"2013"},{"key":"10.1016\/j.micres.2026.128536_bib131","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1413456","article-title":"Viral Bronchiolitis in Children","volume":"374","author":"Meissner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micres.2026.128536_bib132","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.ajt.2023.09.003","article-title":"Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2023","volume":"23","author":"Melgar","year":"2023","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.micres.2026.128536_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004016","article-title":"An Overview of Respiratory Syncytial Virus","volume":"10","author":"Meng","year":"2014","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.micres.2026.128536_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101337","article-title":"Structural basis for respiratory syncytial virus and human metapneumovirus neutralization","volume":"61","author":"Miller","year":"2023","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib135","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1128\/JVI.06744-11","article-title":"The human respiratory syncytial virus matrix protein is required for maturation of viral filaments","volume":"86","author":"Mitra","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106180","article-title":"Clinical characteristics and outcomes of respiratory syncytial virus-associated ARF in immunocompetent patients: A seven-year experience at a tertiary hospital in France","volume":"89","author":"Mokrani","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.micres.2026.128536_bib137","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.3390\/jcm14093175","article-title":"Role of Respiratory Viruses in Severe Acute Respiratory Failure","volume":"14","author":"Mokrani","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.micres.2026.128536_bib138","first-page":"487","article-title":"FDA approves mRNA-based RSV vaccine","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micres.2026.128536_bib139","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3390\/v14050912","article-title":"Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication","volume":"14","author":"Murray","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2026.128536_bib140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97658-w","article-title":"Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro","volume":"11","author":"Murray","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micres.2026.128536_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/v15020452","article-title":"Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication","volume":"15","author":"Nakajima","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2026.128536_bib142","doi-asserted-by":"crossref","first-page":"l5021","DOI":"10.1136\/bmj.l5021","article-title":"Respiratory syncytial virus infection in adults","volume":"366","author":"Nam","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.micres.2026.128536_bib143","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7883\/yoken.JJID.2016.463","article-title":"Surveillance of Severe Acute Respiratory Infection (SARI) for Hospitalized Patients in Northern Vietnam, 2011-2014","volume":"70","author":"Nguyen","year":"2017","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198277","article-title":"Repurposing of antiparasitic niclosamide to inhibit respiratory syncytial virus (RSV) replication","volume":"295","author":"Niyomdecha","year":"2021","journal-title":"Virus Res"},{"key":"10.1016\/j.micres.2026.128536_bib145","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.vaccine.2015.02.039","article-title":"Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya","volume":"33","author":"Nyiro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.micres.2026.128536_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288271","article-title":"Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results","volume":"18","author":"Oey","year":"2023","journal-title":"PLOS ONE"},{"key":"10.1016\/j.micres.2026.128536_bib147","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.resinv.2024.06.003","article-title":"Burden of respiratory syncytial virus infections in older adults with acute respiratory infection in Japan: An epidemiological study among outpatients","volume":"62","author":"Ohbayashi","year":"2024","journal-title":"Respir. Invest."},{"key":"10.1016\/j.micres.2026.128536_bib148","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults","volume":"388","author":"Papi","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micres.2026.128536_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110302","article-title":"Epidemiological characteristics of non-polio enteroviruses in respiratory infections: An Italian multicentre retrospective study, 2022\u20132023","volume":"603","author":"Pellegrinelli","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.micres.2026.128536_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2024.105681","article-title":"Sequence analysis of respiratory syncytial virus cases reveals a novel subgroup -B strain circulating in north-central Italy after pandemic restrictions","volume":"173","author":"Pierangeli","year":"2024","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib151","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02312-19","article-title":"Assessment of Drug Resistance during Phase 2b Clinical Trials of Presatovir in Adults Naturally Infected with Respiratory Syncytial Virus","volume":"64","author":"Porter","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micres.2026.128536_bib152","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/infdis\/jiad010","article-title":"Respiratory Syncytial Virus Infection: Old Challenges and New Approaches","volume":"228","author":"Ramilo","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205124","article-title":"Epidemiology of severe acute respiratory infections from hospital-based surveillance in Madagascar, November 2010 to July 2013","volume":"13","author":"Razanajatovo","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.micres.2026.128536_bib154","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.vacun.2023.12.001","article-title":"Current situation of intranasal attenuated vaccines against respiratory syncytial virus in the child population","volume":"25","author":"Reina","year":"2024","journal-title":"Vacunas Engl. Ed."},{"key":"10.1016\/j.micres.2026.128536_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1219846","article-title":"The RSV F p27 peptide: current knowledge, important questions","volume":"14","author":"Rezende","year":"2023","journal-title":"Front. Microbiol"},{"key":"10.1016\/j.micres.2026.128536_bib156","first-page":"1","article-title":"Spatial resolution of virus replication: RSV and cytoplasmic inclusion bodies","volume":"116","author":"Risso-Ballester","year":"2023","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.micres.2026.128536_bib157","doi-asserted-by":"crossref","first-page":"12790","DOI":"10.3390\/ijms252312790","article-title":"Interaction of Human Respiratory Syncytial Virus (HRSV) Matrix Protein with Resveratrol Shows Antiviral Effect","volume":"25","author":"Rodrigues","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micres.2026.128536_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2025.101477","article-title":"Status of advanced respiratory syncytial virus antiviral therapeutics 2025","volume":"73","author":"Ruckel","year":"2025","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib159","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41541-023-00734-7","article-title":"The road to approved vaccines for respiratory syncytial virus","volume":"8","author":"Ruckwardt","year":"2023","journal-title":"Npj Vaccin."},{"key":"10.1016\/j.micres.2026.128536_bib160","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/s41467-024-45241-y","article-title":"Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor","volume":"15","author":"Sake","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micres.2026.128536_bib161","unstructured":"Salud, S. de, 2026. Bolet\u00ednEpidemiol\u00f3gico Sistema Nacional de Vigilancia Epidemiol\u00f3gica Sistema \u00danico de Informaci\u00f3n [WWW Document]. gob.mx. URL \u3008http:\/\/www.gob.mx\/salud\/documentos\/boletinepidemiologico-sistema-nacional-de-vigilancia-epidemiologica-sistema-unico-de-informacion-417103\u3009 (accessed 2.3.26)."},{"key":"10.1016\/j.micres.2026.128536_bib162","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1128\/JVI.06274-11","article-title":"Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells","volume":"86","author":"San-Juan-Vergara","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib163","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00695-19","article-title":"CD4+ T Cells Drive Lung Disease Enhancement Induced by Immunization with Suboptimal Doses of Respiratory Syncytial Virus Fusion Protein in the Mouse Model","volume":"93","author":"Schneider-Ohrum","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106046","article-title":"Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4\u2032-fluorouridine","volume":"233","author":"Schrell","year":"2025","journal-title":"Antivir. Res"},{"key":"10.1016\/j.micres.2026.128536_bib165","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/infdis\/jiv323","article-title":"Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia","volume":"213","author":"Self","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595297","article-title":"Understanding Early-Life Adaptive Immunity to Guide Interventions for Pediatric Health","volume":"11","author":"Semmes","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micres.2026.128536_bib167","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.7150\/ijbs.64762","article-title":"Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies","volume":"17","author":"Shang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.micres.2026.128536_bib168","article-title":"Respiratory Syncytial Virus (RSV): A Comprehensive Overview From Basic Biology to Clinical Prevention and Control","author":"Shi","year":"2025","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.micres.2026.128536_bib169","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.micres.2026.128536_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1231641","article-title":"Diabetes and bacterial co-infection are two independent risk factors for respiratory syncytial virus disease severity","volume":"10","author":"Sivgin","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.micres.2026.128536_bib171","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01385-24","article-title":"A new mechanism of respiratory syncytial virus entry inhibition by small-molecule to overcome K394R-associated resistance","volume":"15","author":"Song","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.micres.2026.128536_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2025.110413","article-title":"The link between respiratory syncytial virus (RSV) morphogenesis and virus transmission: Towards a paradigm for understanding RSV transmission in the upper airway","volume":"604","author":"Sugrue","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.micres.2026.128536_bib173","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cid\/cit767","article-title":"Medically Attended Respiratory Syncytial Virus Infections in Adults Aged \u226550 Years: Clinical Characteristics and Outcomes","volume":"58","author":"Sundaram","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib174","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/v15020341","article-title":"Biochemistry of the Respiratory Syncytial Virus L Protein Embedding RNA Polymerase and Capping Activities","volume":"15","author":"Sutto-Ortiz","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2026.128536_bib175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009562","article-title":"The methyltransferase domain of the Respiratory Syncytial Virus L protein catalyzes cap N7 and 2\u2019-O-methylation","volume":"17","author":"Sutto-Ortiz","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micres.2026.128536_bib176","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01205-21","article-title":"Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein","volume":"95","author":"Tang","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib177","article-title":"Respiratory syncytial virus infection in adult and paediatric patients admitted to intensive care in Australia: A nation-wide comparison with COVID-19","volume":"27","author":"Tang","year":"2025","journal-title":"Crit. Care Resusc."},{"key":"10.1016\/j.micres.2026.128536_bib178","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1128\/JCM.00209-07","article-title":"Identification of dengue virus in respiratory specimens from a patient who had recently traveled from a region where dengue virus infection is endemic","volume":"45","author":"Tavakoli","year":"2007","journal-title":"J. Clin. Microbiol"},{"key":"10.1016\/j.micres.2026.128536_bib179","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1093\/pch\/pxz151","article-title":"Palivizumab Prophylaxis for infants 29\u201332 weeks gestation at birth: A 10-year audit from Vancouver Island using BC Guidelines","volume":"26","author":"Taylor","year":"2021","journal-title":"Paediatr. Child Health"},{"key":"10.1016\/j.micres.2026.128536_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00225","article-title":"Respiratory Syncytial Virus\u2019s Non-structural Proteins: Masters of Interference","volume":"10","author":"Thornhill","year":"2020","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"10.1016\/j.micres.2026.128536_bib181","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1099\/vir.0.049254-0","article-title":"RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function","volume":"94","author":"Tian","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib182","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268820000400","article-title":"The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis","volume":"148","author":"Tin Tin Htar","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.micres.2026.128536_bib183","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/pathogens12101259","article-title":"Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines","volume":"12","author":"Topalidou","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.micres.2026.128536_bib184","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/JVI.02862-12","article-title":"Respiratory syncytial virus polymerase can initiate transcription from position 3 of the leader promoter","volume":"87","author":"Tremaglio","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2026.128536_bib185","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/90675","article-title":"CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein","volume":"2","author":"Tripp","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.micres.2026.128536_bib186","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11262-019-01646-2","article-title":"The BeWo cell line derived from a human placental choriocarcinoma is permissive for respiratory syncytial virus infection","volume":"55","author":"Vel\u00e1zquez-Cervantes","year":"2019","journal-title":"Virus Genes"},{"key":"10.1016\/j.micres.2026.128536_bib187","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1021\/acs.jmedchem.0c00226","article-title":"Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1 H -indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2 H -imidazo[4,5- c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus","volume":"63","author":"Vendeville","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micres.2026.128536_bib188","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1080\/21645515.2020.1843336","article-title":"Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children","volume":"17","author":"Viguria","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.micres.2026.128536_bib189","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1532-5415.1995.tb06384.x","article-title":"Can Respiratory Syncytial Virus and Influenza A be Distinguished Clinically in Institutionalized Older Persons?","volume":"43","author":"Wald","year":"1995","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.micres.2026.128536_bib190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccm.2016.11.010","article-title":"Respiratory Syncytial Virus infection: an illness for all ages","volume":"38","author":"Walsh","year":"2017","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.micres.2026.128536_bib191","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/jm5017279","article-title":"Discovery of 4\u2032-Chloromethyl-2\u2032-deoxy-3\u2032,5\u2032-di- O -isobutyryl-2\u2032-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micres.2026.128536_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108553","article-title":"Computational discovery of RSV Pre-F inhibitors via reinforcement learning-driven ab initio design from natural fragment libraries","volume":"119","author":"Wang","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.micres.2026.128536_bib193","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s15010-025-02484-1","article-title":"RSV is the main cause of severe respiratory infections in infants and young children in Germany - data from the prospective, multicenter PAPI study 2021-2023","volume":"53","author":"Wetzke","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.micres.2026.128536_bib194","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0950268804003450","article-title":"The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection","volume":"133","author":"White","year":"2005","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.micres.2026.128536_bib195","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micres.2026.128536_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2025.103183","article-title":"Mexican Interdisciplinary Consensus on the Diagnosis and Preventive Measures for Respiratory Syncytial Virus Infections","volume":"56","author":"Wong-Chew","year":"2025","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.micres.2026.128536_bib197","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/v12030345","article-title":"Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections","volume":"12","author":"Wu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2026.128536_bib198","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/gutjnl-2013-306155","article-title":"Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C","volume":"64","author":"Xiao","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.micres.2026.128536_bib199","doi-asserted-by":"crossref","unstructured":"Xu, M., Wang, Q., Wang, Y., Tong, X., Yi, L., Lin, J., Zou, J., Zhao, S., Yang, J., Chu, H.Y., Yu, H., 2025. Transplacental transfer efficiency and longitudinal dynamics of antibodies against RSV in Chinese children from birth to 8 years: a paired mother\u2013neonate cohort study. https:\/\/doi.org\/10.1101\/2025.10.15.25338064.","DOI":"10.1101\/2025.10.15.25338064"},{"key":"10.1016\/j.micres.2026.128536_bib200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1248\/cpb.c19-00895","article-title":"Design and Synthesis of 2-(1-Alkylaminoalkyl)pyrazolo[1,5-a]pyrimidines as New Respiratory Syncytial Virus Fusion Protein Inhibitors","volume":"68","author":"Yamaguchi-Sasaki","year":"2020","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.micres.2026.128536_bib201","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013864","article-title":"Molecular mechanism of ziresovir targeting the fusion glycoprotein of respiratory syncytial virus","volume":"22","author":"Yan","year":"2026","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.micres.2026.128536_bib202","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.apsb.2025.02.015","article-title":"Advances in development of antiviral strategies against respiratory syncytial virus","volume":"15","author":"Yang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.micres.2026.128536_bib203","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.apsb.2025.02.015","article-title":"Advances in development of antiviral strategies against respiratory syncytial virus","volume":"15","author":"Yang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.micres.2026.128536_bib204","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/microorganisms8050713","article-title":"Systematic review of the respiratory syncytial virus (RSV) prevalence, genotype distribution, and seasonality in children from the Middle East and North Africa (MENA) region","volume":"8","author":"Yassine","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.micres.2026.128536_bib205","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00420-24","article-title":"4\u2032-Fluorouridine inhibits alphavirus replication and infection in vitro and in vivo","volume":"15","author":"Yin","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.micres.2026.128536_bib206","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2502984","article-title":"Clesrovimab for prevention of RSV disease in healthy infants","volume":"393","author":"Zar","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micres.2026.128536_bib207","article-title":"Efficacy and safety of vaccines to prevent respiratory syncytial virus infection in infants and older adults: a systematic review and meta-analysis","volume":"146","author":"Zeng","year":"2024","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib208","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2352-4642(25)00067-7","article-title":"Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-up","volume":"9","author":"Zhang","year":"2025","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.micres.2026.128536_bib209","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1021\/acs.jmedchem.9b00654","article-title":"Discovery of ziresovir as a potent, selective, and orally bioavailable respiratory syncytial virus fusion protein inhibitor","volume":"62","author":"Zheng","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micres.2026.128536_bib210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1084139","article-title":"Immune escaping of the novel genotypes of human respiratory syncytial virus based on gene sequence variation","volume":"13","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micres.2026.128536_bib211","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/infdis\/jiy189","article-title":"Prevalence and significance of substitutions in the fusion protein of respiratory syncytial virus resulting in neutralization escape from antibody MEDI8897","volume":"218","author":"Zhu","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micres.2026.128536_bib212","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/infdis\/jiq100","article-title":"Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and\/or motavizumab","volume":"203","author":"Zhu","year":"2011","journal-title":"J. Infect. Dis."}],"container-title":["Microbiological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094450132600100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094450132600100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:16:03Z","timestamp":1778498163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S094450132600100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":212,"alternative-id":["S094450132600100X"],"URL":"https:\/\/doi.org\/10.1016\/j.micres.2026.128536","relation":{},"ISSN":["0944-5013"],"issn-type":[{"value":"0944-5013","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targeting of Respiratory Syncytial Virus: Current pharmacological options and future directions in antiviral development","name":"articletitle","label":"Article Title"},{"value":"Microbiological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micres.2026.128536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128536"}}